Does an HbA1c of 6.3% indicate chronic prediabetes-range dysglycemia?

A hemoglobin A1c (HbA1c) of 6.3% is clinically meaningful because it reflects cumulative glucose exposure, rather than the transient influences that can affect a single glucose result.

Clinical interpretation

• HbA1c 6.3% falls in the accepted prediabetes range of 5.7%–6.4% and is below the HbA1c diagnostic threshold for diabetes.
• This result supports sustained dysglycemia, not simply one elevated glucose value after a meal, acute illness, stress response, or other short-term circumstance.
• HbA1c reflects nonenzymatic glycation of hemoglobin over approximately 8–12 weeks, with more recent glucose levels contributing relatively more to the result.

Mechanistic and measurement considerations

• The interpretation relies on HbA1c accurately reflecting average glycemic exposure and on relatively typical red-blood-cell survival.
• Shortened erythrocyte survival or increased turnover—such as hemolysis, blood loss, erythropoietin treatment, pregnancy, and often advanced chronic kidney disease—can yield a falsely low HbA1c.
• Iron, vitamin B12, or folate deficiency, and other settings associated with prolonged erythrocyte survival, may raise HbA1c independently of true glucose exposure. Recent transfusion can make the direction of bias unpredictable.

Clinical implications

• If there are factors likely to alter HbA1c interpretation, or if symptoms or measured plasma glucose are discordant with HbA1c, confirmation with fasting plasma glucose and/or an oral glucose-tolerance test is appropriate.

Bottom line

• An HbA1c of 6.3% strongly supports chronic prediabetes-range dysglycemia over recent weeks, rather than a single isolated glucose elevation, provided no condition is materially distorting HbA1c accuracy.